시장보고서
상품코드
1455662

3D 바이오프린팅 인체조직 시장 : 생체재료 유형별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

3D Bio-Printed Human Tissue Market, By Biomaterial type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 288 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

3D 바이오프린팅 인체조직 시장 규모는 2023년 28억 54만 달러로 평가되었고, 2024년부터 2032년까지 연평균 9.85% 성장할 것으로 예상됩니다.

3D 바이오프린팅 인체조직 시장 - 시장 역학

용도 확대로 이어지는 기술 발전, 개인 맞춤형 3D 바이오프린팅 조직공학 및 장기 대체에 대한 수요 증가가 시장 수요를 촉진

3D 바이오프린팅 인체 조직 시장의 성장 촉진요인으로는 기술 발전으로 인한 응용 분야 확대, 개인 맞춤형 3D 바이오프린팅 조직 공학 및 장기 대체에 대한 수요 증가 등이 있습니다. 복잡한 조직을 공학적으로 구축하기 위한 유망한 접근법이며, 원래 인간 조직의 복잡한 계층과 복잡성을 모방하기 위해 세포 성분을 세밀하게 제어할 수 있다는 점을 강조하고 있습니다. 최근 혁신적인 형태의 살아있는 빌딩 블록과 이를 가능하게 하는 바이오프린팅 기술의 발전은 보다 복잡하고 기능적인 조직을 공학적으로 제작할 수 있는 능력을 크게 확장하여 질병 모델, 미세 생리적 시스템 및 바이오봇 공학에 대한 응용을 더욱 확장하고 있습니다. 또한 Science Daily지 2021년 3월호에 보도된 바와 같이, 스웨덴 룬드대학의 연구진은 환자 세포를 사용하여 인간 크기의 작은 호흡기를 3D 바이오프린팅할 수 있는 새로운 바이오 잉크를 개발했습니다. 이 3D 프린팅 구성은 생체 적합성이 있으며 이식된 재료에 새로운 혈관의 성장을 지원합니다. 결과적으로 이러한 발전은 3D 바이오프린팅 인체 조직에 대한 수요를 촉진하고 시장 성장을 가속할 것으로 예상됩니다.

3D 바이오프린팅 인체 조직 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032) 동안 매년 약 9.85%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

바이오 소재 유형별 세분화에 따라 2023년에는 천연 소재가 가장 큰 시장 점유율을 보일 것으로 예측됐습니다.

용도별로는 2023년 의약품 검사 및 개발이 주요 유형으로 부상할 것으로 예상됩니다.

지역별로는 북미가 2023년 주요 수익원으로 부상했습니다.

3D 바이오프린팅 인체조직 시장 - 세분화 분석 :

세계 3D 바이오프린팅 인체조직 시장은 바이오 소재 유형, 용도, 지역에 따라 세분화됩니다.

시장은 바이오 소재 유형에 따라 천연과 합성의 두 가지 범주로 나뉩니다. 천연 부문은 2023년 합성 폴리머를 능가하며 바이오 소재의 전망을 지배할 것으로 예상됩니다. 콜라겐과 젤라틴과 같은 재료는 뛰어난 생체 적합성과 생물학적 활성을 나타내며 인간 조직의 세포 외 기질과 매우 유사합니다. 이들은 세포의 접착, 증식 및 분화를 지원하기 때문에 바이오프린팅 응용 분야에 매우 적합합니다. 또한, 천연 고분자는 면역원성 및 생분해성이 우수하여 부작용을 최소화하고 숙주 조직과의 원활한 통합을 가능하게 합니다. 그 결과, 천연 고분자는 바이오프린팅 공정에 선호되는 선택이 되어 재생의학, 조직공학 및 장기 이식의 발전을 촉진하고 있습니다.

이 시장은 용도별로 조직공학, 미용 성형, 의약품 검사 및 개발, 식품 검사, 기타 용도 등 5가지 범주로 분류됩니다. 약물 검사 및 개발이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 약물 검사에서 3D 바이오프린팅 인체조직의 활용은 중요한 역할을 하고 있습니다. 이러한 조직은 동물 실험의 필요성을 크게 줄일 수 있어 윤리적 이점과 비용 효율성을 제공하는 약물 테스트 및 임상시험 응용 분야에 가장 중요합니다. 기존에는 신약 개발을 위해 인위적으로 유발된 환부 조직을 이용한 동물 임상시험이 필요했습니다. 그러나 3D 바이오프린팅된 인체 조직이 등장하면서, 이들 조직이 인간의 생리와 매우 유사하기 때문에 의약품 발명가들은 단기간에 이를 식별하여 인간 의료 시험과 관련된 문제를 해결할 수 있게 되었습니다. 이를 통해 후기 단계의 실패로 인한 손실을 줄일 수 있습니다. 예를 들어, 2021년 9월 국립의학도서관이 발표한 논문에 따르면, 3D 프린팅은 환자 유래 세포로 구성된 생체 재료를 정확하게 증착하여 질병에 걸린 인체의 자연 환경을 재현함으로써 기존 약물 스크리닝 플랫폼을 강화할 수 있다고 합니다.

3D 바이오프린팅 인체 조직 시장 - 지리적 통찰력

지리적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 분포되어 있습니다. 이 지역은 비즈니스를 가져 오는 국가에 따라 더 세분화됩니다.

3D 바이오프린팅 인체조직 시장 - 경쟁 상황:

3D 바이오프린팅 인체조직 전문 기업들은 재생의료와 조직공학의 선구자적 역할을 하고 있습니다. 이 기업들은 바이오 프린팅 공정을 개선하고, 생체 재료 배합을 최적화하고, 인쇄된 구조물 내 세포의 생존율과 기능을 향상시키기 위해 연구개발에 투자하고 있습니다. 또한, 이들 기업은 학술 기관, 의료 서비스 제공업체 및 제약 회사와 협력하여 신약 개발, 질병 모델링 및 개인 맞춤형 의료에 대한 응용 가능성을 모색하고 있습니다. 또한, 마케팅 노력은 3D 바이오프린팅된 인체 조직의 능력과 조직 복구, 재생 및 대체를 위한 혁신적인 솔루션을 제공함으로써 헬스케어에 혁명을 일으킬 수 있는 가능성에 대한 인식을 높이는 것을 목표로 하고 있습니다. 또한, 주요 시장 참여자 및 정부 기관이 자금을 지원하는 제품 혁신 및 공동 연구 증가는 예측 기간 동안 시장 성장을 뒷받침할 것으로 보입니다.

목차

제1장 3D 바이오프린팅 인체조직 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 3D 바이오프린팅 인체조직 주요 시장 동향

  • 3D 바이오 프린팅 인체조직 시장 성장 촉진요인
  • 3D 바이오 프린팅 인체조직 시장 성장 억제요인
  • 3D 바이오 프린팅 인체조직 시장 기회
  • 3D 바이오 프린팅 인체조직 시장 향후 동향

제4장 3D 바이오프린팅 인체조직 : 산업 조사

  • PEST 분석
  • Porter의 Five Forces 분석
  • 성장 전망 매핑
  • 규제 구조 분석

제5장 3D 바이오프린팅 인체조직 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 3D 바이오프린팅 인체조직 시장 구도

  • 3D 바이오 프린팅 인체조직 시장 점유율 분석, 2023년
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신규 기업 분석

제7장 3D 바이오프린팅 인체조직 시장 - 바이오소재 유형별

  • 개요
    • 부문 점유율 분석, 바이오소재 유형별
    • 천연
    • 합성

제8장 3D 바이오프린팅 인체조직 시장 - 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 인체조직 공학
    • 미용성형외과
    • 의약품 검사 및 개발
    • 식품 검사
    • 기타

제9장 3D 바이오프린팅 인체조직 시장 - 지역별

  • 서론
  • 북미
    • 개요
    • 북미 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제10장 주요 벤더 분석 - 3D 바이오프린팅 인체조직 산업

  • 경쟁 대시보드
  • 기업 개요
    • Shinano Kenshi
    • MinebeaMitsumi
    • Nidec Servo
    • Moons'
    • Sanyo Denki
    • Oriental Motor
    • Tamagawa Seiki, and Fulling Motor
    • Nippon Pulse Motor
    • Nanotec
    • AMETEK
    • Sonceboz
    • Phytron
    • MICRO STEP GmbH
    • STOGRA.
    • Others

제11장 애널리스트의 전방위 전망

LSH 24.04.30

REPORT HIGHLIGHT

3D bio-printed human tissue Market size was valued at USD 2,800.54 Million in 2023, expanding at a CAGR of 9.85% from 2024 to 2032.

3D bio-printed human tissue represents a groundbreaking technology that involves the layer-by-layer construction of living tissue structures utilizing biocompatible materials and living cells. This state-of-the-art method enables precise cell and biomaterial deposition to emulate the intricate architecture and functionality of native tissues and organs. Through the utilization of advanced bioprinting techniques, researchers and scientists can fabricate intricate tissue frameworks incorporating vascular networks, cellular organization, and tissue-specific functionalities.

3D bio-printed human tissue Market- Market Dynamics

Technological advancements leading to expanded applications and the growing demand for personalized 3D bioprinted tissue engineering and organ replacement to propel market demand

Key drivers of 3D bio-printed human tissue market growth include technological advancements leading to expanded applications and the growing demand for personalized 3D bioprinted tissue engineering and organ replacement. A March 2022 article published by ScienceDirect highlights 3D bioprinting as a promising approach for engineering complex tissues, offering meticulous control over cellular components to mimic the intricate hierarchy and complexity of native human tissues. Recent progress in innovative forms of living building blocks and enabling bioprinting techniques has significantly broadened the capacity to engineer more complex and functional tissues, further extending their applications in engineering disease models, microphysiological systems, and biobots. Additionally, as reported by a March 2021 article from Science Daily, researchers at Lund University in Sweden have developed a new bio-ink facilitating the 3D bioprinting of small human-sized airways using patient cells. These 3D-printed constructs are biocompatible and support the growth of new blood vessels into the transplanted material. Consequently, such advancements are anticipated to fuel the demand for 3D bioprinted human tissues, driving market growth.

3D bio-printed human tissue Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.85% over the forecast period (2024-2032)

Based on Biomaterial type segmentation, Natural was predicted to show maximum market share in the year 2023

Based on Application segmentation, Drug Testing and Development was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

3D bio-printed human tissue Market- Segmentation Analysis:

The Global 3D bio-printed human tissue Market is segmented on the basis of Biomaterial type, Application, and Region.

The market is divided into two categories based on Biomaterial type: natural and synthetic. Natural segment dominate the biomaterials landscape, surpassing synthetic polymers in 2023. Materials such as collagen and gelatin exhibit exceptional biocompatibility and bioactivity, closely resembling the extracellular matrix of human tissues. They support cell adhesion, proliferation, and differentiation, making them highly desirable for bio-printing applications. Moreover, natural polymers offer advantages in terms of immunogenicity and biodegradability, minimizing adverse reactions and enabling seamless integration with host tissue. Consequently, natural polymers remain the preferred choice for bio-printing processes, driving advancements in regenerative medicine, tissue engineering, and organ transplantation.

The market is divided into five categories based on Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing and Other Applications. Drug Testing and Development are expected to hold a significant market share. The utilization of 3D bioprinted human tissue in drug testing plays a crucial role. These tissues are of paramount importance for drug testing and clinical trial applications, with the potential to significantly reduce the necessity for animal trials, thereby offering ethical benefits and cost-effectiveness. Traditionally, new drug development involved clinical trials on animals with artificially-induced affected tissues. However, with the introduction of 3D bioprinted human tissue, drug inventers can address problems related with human medical trials by identifying them within a short period, as these tissues closely resemble human physiology. This reduces losses incurred during late-stage failures. For instance, according to a September 2021 article published by the National Library of Medicine, 3D printing enhances existing drug screening platforms by precisely depositing biomaterials comprising patient-derived cells and reproducing the natural environment of the diseased human body.

3D bio-printed human tissue Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

3D bio-printed human tissue Market- Competitive Landscape:

In the market, companies specializing in 3D bio-printed human tissue are pioneers in regenerative medicine and tissue engineering. They invest in research and development to refine bioprinting processes, optimize biomaterial formulations, and enhance cell viability and functionality within printed constructs. Additionally, these companies collaborate with academic institutions, healthcare providers, and pharmaceutical companies to explore potential applications in drug discovery, disease modeling, and personalized medicine. Furthermore, marketing endeavors aim to raise awareness of the capabilities of 3D bio-printed human tissue and its potential to revolutionize healthcare by providing innovative solutions for tissue repair, regeneration, and replacement. Furthermore, increasing product innovation and collaborations funded by key market players and government agencies will support market growth over the forecast period.

Recent Developments:

In November 2022, Northrop Grumman's 18th Commercial Resupply Services (NG-18) mission launched an upgraded version of Redwire Space's BioFabrication Facility (BFF), a 3D bioprinter capable of printing human tissue. Sponsored by the ISS National Laboratory, this project paved the way for in-space bioprinting tissues to aid patients back on Earth.

In November 2022, Avay Biosciences introduced an indigenous 3D printer, Mito Plus, capable of printing human tissues, adding to the market's growth through product innovations.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL 3D BIO-PRINTED HUMAN TISSUE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Shinano Kenshi

MinebeaMitsumi

Nidec Servo

Moons'

Sanyo Denki

Oriental Motor

Tamagawa Seiki, and Fulling Motor

Nippon Pulse Motor

Nanotec

AMETEK

Sonceboz

Phytron

MICRO STEP GmbH

STOGRA.

Others

GLOBAL 3D BIO-PRINTED HUMAN TISSUE MARKET, BY BIOMATERIAL TYPE- MARKET ANALYSIS, 2019 - 2032

  • Natural
  • Synthetic

GLOBAL 3D BIO-PRINTED HUMAN TISSUE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Tissue Engineering
  • Cosmetic Surgery
  • Drug Testing and Development
  • Food Testing
  • Other Applications

GLOBAL 3D BIO-PRINTED HUMAN TISSUE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.3D bio-printed human tissue Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.3D bio-printed human tissue Market Snippet by Biomaterial type
    • 2.1.2.3D bio-printed human tissue Market Snippet by Application
    • 2.1.3.3D bio-printed human tissue Market Snippet by Country
    • 2.1.4.3D bio-printed human tissue Market Snippet by Region
  • 2.2.Competitive Insights

3.3D bio-printed human tissue Key Market Trends

  • 3.1.3D bio-printed human tissue Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.3D bio-printed human tissue Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.3D bio-printed human tissue Market Opportunities
  • 3.4.3D bio-printed human tissue Market Future Trends

4.3D bio-printed human tissue Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.3D bio-printed human tissue Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.3D bio-printed human tissue Market Landscape

  • 6.1.3D bio-printed human tissue Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.3D bio-printed human tissue Market - By Biomaterial type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Biomaterial type, 2023 & 2032 (%)
    • 7.1.2.Natural
    • 7.1.3.Synthetic

8.3D bio-printed human tissue Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Tissue Engineering
    • 8.1.3.Cosmetic Surgery
    • 8.1.4.Drug Testing and Development
    • 8.1.5.Food Testing
    • 8.1.6.Other Applications

9.3D bio-printed human tissue Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.3D bio-printed human tissue Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.3D bio-printed human tissue Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.3D bio-printed human tissue Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.3D bio-printed human tissue Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.3D bio-printed human tissue Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Biomaterial type, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- 3D bio-printed human tissue Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Shinano Kenshi
    • 10.2.2.MinebeaMitsumi
    • 10.2.3.Nidec Servo
    • 10.2.4.Moons'
    • 10.2.5.Sanyo Denki
    • 10.2.6.Oriental Motor
    • 10.2.7.Tamagawa Seiki, and Fulling Motor
    • 10.2.8.Nippon Pulse Motor
    • 10.2.9.Nanotec
    • 10.2.10.AMETEK
    • 10.2.11.Sonceboz
    • 10.2.12.Phytron
    • 10.2.13.MICRO STEP GmbH
    • 10.2.14.STOGRA.
    • 10.2.15.Others

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제